These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin. Chou TC, Lin YF, Wu WC, Chu KM. Br J Pharmacol; 2008 Mar; 153(6):1281-7. PubMed ID: 18264124 [Abstract] [Full Text] [Related]
25. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein. Sabetkar M, Naseem KM, Tullett JM, Friebe A, Koesling D, Bruckdorfer KR. Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196 [Abstract] [Full Text] [Related]
26. Inhibition of platelet aggregation by polyaspartoyl L-arginine and its mechanism. Wang YY, Tang ZY, Dong M, Liu XY, Peng SQ. Acta Pharmacol Sin; 2004 Apr; 25(4):469-73. PubMed ID: 15066215 [Abstract] [Full Text] [Related]
29. The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors. Salvemini D, Radziszewski W, Korbut R, Vane J. Br J Pharmacol; 1990 Dec; 101(4):991-5. PubMed ID: 1707709 [Abstract] [Full Text] [Related]
30. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets. Bani D, Bigazzi M, Masini E, Bani G, Sacchi TB. Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945 [Abstract] [Full Text] [Related]
31. The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation. Naseem KM, Chirico S, Mohammadi B, Bruckdorfer KR. Biochem J; 1996 Sep 15; 318 ( Pt 3)(Pt 3):759-66. PubMed ID: 8836116 [Abstract] [Full Text] [Related]
32. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. Belenky SN, Robbins RA, Rennard SI, Gossman GL, Nelson KJ, Rubinstein I. J Lab Clin Med; 1993 Oct 15; 122(4):388-94. PubMed ID: 7693839 [Abstract] [Full Text] [Related]
33. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Mollace V, Salvemini D, Anggard E, Vane J. Br J Pharmacol; 1991 Nov 15; 104(3):633-8. PubMed ID: 1724627 [Abstract] [Full Text] [Related]
35. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R. Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591 [Abstract] [Full Text] [Related]
37. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation. Salvemini D, Masini E, Anggard E, Mannaioni PF, Vane J. Biochem Biophys Res Commun; 1990 Jun 15; 169(2):596-601. PubMed ID: 1972620 [Abstract] [Full Text] [Related]